The Patent Finder

Ucb Biopharma SPRL

80 patents currently held · Updated Nov 15, 2026
119 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 5 name spellings.

Recorded as renamed to Ucb Biopharma SRL (2020)

28
Ending by 2030
Feb 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 2 to 4, 2026 · next Dec 2
  • 3 fees due Jan 9 to 23, 2027 · next Jan 9
  • 2 fees due Feb 6 to 13, 2027 · next Feb 6
  • 2 fees due May 5 to 19, 2027 · next May 5
  • 1 fee due Jun 3, 2027
    The maintenance fee for A Specific Trifluoroethyl Quinoline Analogue For Use In The Treatment Of Sjögren's SyndromS (US 10,493,074) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for Fused Pentacyclic Imidazole Derivatives (US 11,912,721) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
  • 2 fees due Sep 15 to 17, 2027 · next Sep 15
  • 3 fees due Oct 14 to 21, 2027 · next Oct 14
  • 4 fees due Nov 5 to 10, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • 6 terms have ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US D676,552Needle cap for a medication administration device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,888,344Fused thiazole derivatives as kinase inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,910,618Albumin-Binding Conjugates Comprising a Fatty Acid and Peg
In force
 · High confidence
In forceHigh confidence
US 7,989,594Modified Antibody Fab Fragments
In force
 · High confidence
In forceHigh confidence
US 8,633,194Pharmaceutical composition of piperazine derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,617,847Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,890,219Methods of treating an IL-17A mediated pathological condition
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,308,723Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,303,953Antibody molecules which bind IL-17A and IL-17F
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,378,073Process for attaching effector molecules to proteins
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 80 patents shown.
Pro members see all 80.
Pro members: see all 80 patents
Also on record, not counted in the 80: 119 patents in force now held by others · 127 lapsed for an unpaid fee · 24 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 10 abandoned · 35 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited